Background No systematic attempts have been made to estimate the global and regional
prevalence of amphetamine, cannabis, cocaine, and opioid dependence, and quantify their …

Aims To estimate the global prevalence of cocaine and amphetamine dependence and the
burden of disease attributable to these disorders. Methods An epidemiological model was …

Abstract Introduction The Global Burden of Disease (GBD) 2010 study updated the findings
of earlier exercises. It provided regional and global estimates of the burden of disease …

This paper summarises data for the prevalence, correlates, and probable adverse health
consequences of problem use of amphetamines, cannabis, cocaine, and opioids. We …

Background We used data from the Global Burden of Diseases, Injuries, and Risk Factors
Study 2010 (GBD 2010) to estimate the burden of disease attributable to mental and …

We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …

Aims Estimate the prevalence of cannabis dependence and its contribution to the global
burden of disease. Methods Systematic reviews of epidemiological data on cannabis …

Background Alcohol and drug use can have negative consequences on the health,
economy, productivity, and social aspects of communities. We aimed to use data from the …

We did a global review to synthesise data on the prevalence, harms, and interventions for
stimulant use, focusing specifically on the use of cocaine and amphetamines. Modelling …

A chief coroner investigation in British Columbia, Canada, identified an “inordinately high
number” of drug-related deaths related to a “very real and very serious” drug problem, and …